Fawaz et al. reported the synthesis of [18F]lanzoprazole ([18F]LNS) and its subsequent analysis as a potential radiotracer for quantifying aggregated tau protein levels in Alzheimer’s disease (AD) and progressive supramolecular palsy (PSP) [44]. Here, MAPT is linked to Alzheimer disease.